位置：成果数据库 > 期刊 > 期刊详情页
Lactotransferrin could be a novel independent molecular prognosticator of nasopharyngeal carcinoma
  • ISSN号：1423-0380 (Electronic)
  • 期刊名称：Tumour Biol
  • 时间：2015.2.1
  • 页码：675-683
  • 相关项目：TP53基因调控的microRNAs用于鼻咽癌基因治疗和预后预测
作者： Li X|Tan M|Xiong W|Li G|
同期刊论文项目
TP53基因调控的microRNAs用于鼻咽癌基因治疗和预后预测
期刊论文 69 会议论文 1 获奖 4 著作 4
同项目期刊论文
ChIP-seq: a New Technique for Genome-wide Profiling of Protein-DNA Interaction
Dynamic changes of peritoneal macrophages and subpopulations during ulcerative colitis to metastasis
NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with P
The Effect and Mechanism of PLUNC Protein Family Against Inflammation and Carcinogenesis of Nasophar
lncRNAs参与基因表达调控机制的研究进展
染色质免疫沉淀-测序:全基因组范围研究蛋白质-DNA相互作用的新技术
致瘤性DNA病毒的整合机制及致瘤效应
An integrative transcriptomic analysis reveals p53 regulated miRNA, mRNA, and lncRNA networks in nas
miR-199a-5p regulates the expression of metastasis-associated genes in B16F10 melanoma cells
SPLUNC1 is associated with nasopharyngeal carcinoma prognosis and plays an important role in all-tra
Gene Network Modulated by RASSF1A Over-expression in Melanoma A375 Cells
Advances in microRNAs and TP53 Gene Regulatory Network
Evaluation of the prognostic value of TGF-beta superfamily type I receptor and TGF-beta type II rece
The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma
MicroRNA-29 mediates TGF beta 1-induced extracellular matrix synthesis by targeting wnt/beta-catenin
miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma
长链非编码RNA HOTAIR在恶性肿瘤中的研究进展
MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro
Zbtb7 suppresses the expression of CDK2 and E2F4 in liver cancer cells: Implications for the role of
天然免疫分子乳铁蛋白抑制鼻咽癌的发生发展
MicroRNAs与非可控性炎症相关肿瘤
一个肝癌相关长链非编码RNA的克隆及序列分析
PLUNC蛋白家族在抑制鼻咽上皮“炎．癌”演进中的作用和机制
肿瘤异质性：精准医学需破解的难题
长链非编码RNA AFAP1-AS1促进肿瘤侵袭转移
microRNAs与TP53基因调控网络研究进展
MicroRNA-34用于肿瘤治疗的基础研究
生物信息技术加速开发旧药新用途
鼻咽癌相关固有免疫分子及其潜在临床转化前景